Clinical trial

DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes

NCT06983054

Study summary

ClinicalTrials.gov

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention ertugliflozine Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention low salt diet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention high salt diet Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-07-25

PhasePHASE4

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

ertugliflozineDRUG

low salt dietBEHAVIORAL

placeboDRUG

high salt dietBEHAVIORAL

Sponsors & collaborators

Amsterdam UMC, location VUmclead sponsor

Children's Hospital Coloradocollaborator

Mapped research locations

DenverColorado, United States1 AmsterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06983054 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.